Calidi Biotherapeutics, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Calidi Biotherapeutics, Inc. (CLDI) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 2.65 billion shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- Calidi Biotherapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 49.86M shares, a 2855.60% increase year-over-year.
- Calidi Biotherapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 1.69M shares, a 59.12% decline year-over-year.
- Calidi Biotherapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 4.13M shares, a 78.31% decline year-over-year.
- Calidi Biotherapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 19.02M shares.
- Calidi Biotherapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 5.45M shares, a 378.42% increase from fiscal 2024.
- Calidi Biotherapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 1.14M shares, a 71.01% decline from fiscal 2023.
- Calidi Biotherapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.93M shares, a 79.31% decline from fiscal 2022.
- Calidi Biotherapeutics, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 19.01M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 2.65B shares 10-Q · filed 2026-08-13 | |||||||
| 2026-03-31 | 49.86M shares 10-Q · filed 2026-05-14 | |||||||
| 2025-12-31 | 5.45M shares 10-K · filed 2026-03-27 | |||||||
| 2025-09-30 | 5.46M shares 10-Q · filed 2025-11-13 | |||||||
| 2025-06-30 | 105.29M shares 10-Q · filed 2026-08-13 | 1.68M shares 10-Q · filed 2025-08-08 | ||||||
| 2025-03-31 | 1.69M shares 10-Q · filed 2026-05-14 | 20.24M shares 10-Q · filed 2025-05-14 | ||||||
| 2024-12-31 | 1.14M shares 10-K · filed 2026-03-27 | 13.67M shares 10-K · filed 2025-03-31 | ||||||
| 2024-09-30 | 980.00K shares 10-Q · filed 2025-11-13 | 11.76M shares 10-Q · filed 2024-11-12 | ||||||
| 2024-06-30 | 974.00K shares 10-Q · filed 2025-08-08 | 11.69M shares 10-Q · filed 2024-08-13 | ||||||
| 2024-03-31 | 4.13M shares 10-Q · filed 2025-05-14 | 41.28M shares 10-Q · filed 2024-05-14 | ||||||
| 2023-12-31 | 3.93M shares 10-K · filed 2025-03-31 | 39.32M shares 10-K · filed 2024-03-15 | ||||||
| 2023-09-30 | 4.11M shares 10-Q · filed 2024-11-12 | 41.08M shares 10-Q · filed 2023-11-14 | ||||||
| 2023-06-30 | 1.97M shares 10-Q · filed 2024-08-13 | |||||||
| 2023-03-31 | 19.02M shares 10-Q · filed 2024-05-14 | |||||||
| 2022-12-31 | 19.01M shares 10-K · filed 2024-03-15 | |||||||
| 2022-09-30 | 19.40M shares 10-Q · filed 2023-11-14 | |||||||
| 2021-09-30 | 14.90M shares 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |